Pregnant women’s knowledge about and beliefs toward COVID-19 vaccine: a cross-sectional study
10.7774/cevr.2023.12.2.134
- Author:
Osman Samet GUNKAYA
1
;
Arzu Bilge TEKIN
;
Murat YASSA
;
Oguz ARSLAN
;
Kübra KARAKOÇ
;
Nesibe DEMIRTAŞ
;
Canberk USTA
;
Çiğdem Künt İŞGÜDER
;
Niyazi TUĞ
Author Information
1. Department of Obstetrics and Gynecology, Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital, University of Health Sciences Turkey, Istanbul, Turkey
- Publication Type:Original Article
- From:Clinical and Experimental Vaccine Research
2023;12(2):134-142
- CountryRepublic of Korea
- Language:English
-
Abstract:
Purpose:The aim of this study was to determine the scope of knowledge, attitudes, and behaviors of pregnant women about the coronavirus disease 2019 (COVID-19) vaccine.
Materials and Methods:A total of 886 pregnant women were recruited for the study. A cross-sectional questionnaire was conducted on these selected participants. Data about past infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), SARS-CoV-2 infection of closely related people, and deaths due to COVID-19 among their relatives were questioned.
Results:The rate of vaccination was higher (64.1%) in pregnant women with higher education levels. Informing about the vaccine, especially by health professionals, showed that the rates of vaccination (25%) increased (p<0.001). In addition, a significant increase was observed in vaccination rates with increasing age and financial income (p<0.001).
Conclusion:The main limitation of our study is that the vaccine, which was approved for “emergency use”, was just started to be administered to pregnant women during the study. Our findings show that our target audience, low-income, low-education, younger pregnant women should be given more attention than those who apply to the doctor for routine follow-up.
